To evaluate the efficacy and safety of percutaneous cryoablation (PCA) in treating spinal metastases, which are common in cancer patients and often lead to severe pain and disability.
Key Findings:
PCA effectively reduces pain and opioid dependence in patients with spinal metastases, with significant statistical evidence.
The procedure allows for real-time monitoring and precise targeting of tumors, enhancing treatment accuracy.
Outcomes indicate PCA is a viable option for patients who cannot tolerate surgery, with a favorable safety profile.
Interpretation:
PCA shows promise as a minimally invasive treatment for spinal metastases, offering significant pain management benefits and lower risks to surrounding tissues compared to traditional therapies like cEBRT and SBRT.
Limitations:
Limited number of studies included in the analysis, which may affect generalizability.
Most studies were retrospective, potentially introducing bias and limiting the strength of conclusions.
Variability in PCA techniques and patient selection criteria across studies may impact outcome consistency.
Conclusion:
PCA is a promising treatment modality for spinal metastases, offering effective pain relief and safety, but further research is needed to optimize patient selection and treatment protocols, particularly in diverse patient populations.
by Mohammad Sadegh Fallahi, S. Farzad Maroufi, S. Parmis Maroufi, MirHojjat Khorasanizadeh, Leonardo José Monteiro de Macêdo Filho, Konstantinos Margetis, Daipayan Guha, Claudio E. Tatsui, Alireza Mansouri
